<DOC>
	<DOCNO>NCT01795365</DOCNO>
	<brief_summary>Active Surveillance manages select men prostate cancer expectantly curative intent . This mean men carefully select subsequently actively observed order possibility offer curative treatment tumor seem progress . The goal study validate treatment option Active Surveillance men localize , well differentiated prostate cancer , order limit amount overtreatment . A number key point study , pathological finding radical prostatectomy specimen , effect expectancy quality life .</brief_summary>
	<brief_title>Active Surveillance 2 Groups Patients With Localized Prostate Cancer</brief_title>
	<detailed_description>Objectives : Primary - To evaluate equivalence time active surveillance active treatment group Epstein + expand active surveillance group ( Epstein - ) Secondary - To evaluate role diffusion-weighted MRI ( DW-MRI ) initial diagnosis follow-up patient active surveillance - To evaluate role BCAR-1 predict clinical outcome localize prostate cancer - To evaluate proportion patient discontinue active surveillance - To evaluate mortality 10 , 15 20 year inclusion study - To evaluate time radical treatment - To evaluate time metastatic disease - To evaluate patient quality life</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Localized adenocarcinoma prostate Gleason score 3+3 ( group I patient ) 3+4 ( group II patient ) Percentage tumor biopsy invasion &lt; 50 % and/or size maximum 8 mm With number positive tumor biopsy ≤3 ( group I patient ) ≤ 5 ( group II patient ) TNM stage T12a N0 M0 ( group I patient ) ; TNM stage T12c N0 M0 ( group II patient ) PSA level diagnosis &lt; 10 ng/ml group I patient ; &lt; 15 ng/ml group II patient Tumor volume negative ( group I patient ) ; positive ( group II patient ) Absence extracapsular extension Life expectancy &gt; 10 year Signed informed consent Patient elect active surveillance prefer management plan prostate cancer Previous treatment prostate cancer ( include hormonal therapy , radiation therapy , surgery chemotherapy ) Patients hypogonadism</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>